[1]
“Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis”, OH&RM, vol. 6, no. 3, pp. 44–53, Sep. 2025, doi: 10.38045/ohrm.2025.3.04.